GS
PCRX icon

Gagnon Securities’s Pacira BioSciences PCRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$8.8M Buy
368,353
+60,019
+19% +$1.43M 1.79% 24
2025
Q1
$7.66M Sell
308,334
-13,409
-4% -$333K 1.69% 23
2024
Q4
$6.06M Buy
321,743
+14,800
+5% +$279K 1.22% 26
2024
Q3
$4.62M Sell
306,943
-289,648
-49% -$4.36M 0.92% 33
2024
Q2
$17.1M Buy
596,591
+47,623
+9% +$1.36M 3.84% 5
2024
Q1
$16M Buy
548,968
+3,389
+0.6% +$99K 3.8% 5
2023
Q4
$18.4M Sell
545,579
-19,850
-4% -$670K 4.42% 5
2023
Q3
$17.3M Buy
565,429
+6,220
+1% +$191K 4.35% 5
2023
Q2
$22.4M Sell
559,209
-2,501
-0.4% -$100K 4.66% 4
2023
Q1
$22.9M Sell
561,710
-1,705
-0.3% -$69.6K 4.82% 4
2022
Q4
$21.8M Sell
563,415
-11,193
-2% -$432K 4.8% 3
2022
Q3
$30.6M Sell
574,608
-19,784
-3% -$1.05M 6.72% 1
2022
Q2
$34.7M Sell
594,392
-16,541
-3% -$964K 7.26% 1
2022
Q1
$46.6M Sell
610,933
-2,857
-0.5% -$218K 7.6% 1
2021
Q4
$36.9M Buy
613,790
+43,147
+8% +$2.6M 5.54% 4
2021
Q3
$32M Buy
570,643
+71,310
+14% +$3.99M 4.75% 3
2021
Q2
$30.3M Buy
499,333
+44,484
+10% +$2.7M 4.3% 5
2021
Q1
$31.9M Buy
454,849
+19,894
+5% +$1.39M 4.85% 4
2020
Q4
$26M Buy
434,955
+9,288
+2% +$556K 4.14% 6
2020
Q3
$25.6M Buy
425,667
+3,526
+0.8% +$212K 5.46% 3
2020
Q2
$22.2M Buy
422,141
+14,982
+4% +$786K 5.36% 3
2020
Q1
$13.7M Buy
407,159
+21,247
+6% +$712K 4.64% 5
2019
Q4
$17.5M Sell
385,912
-1,467
-0.4% -$66.5K 3.83% 7
2019
Q3
$14.7M Buy
387,379
+108,766
+39% +$4.14M 3.49% 8
2019
Q2
$12.1M Buy
+278,613
New +$12.1M 2.61% 14